Art
J-GLOBAL ID:201002252391306313   Reference number:10A0845291

診療報酬明細書(レセプト)データベースから2型糖尿病合併症および大血管症の病期進展と医療費の関係を明らかにするための患者情報を抽出する方法の検討

Author (15):
Material:
Volume:Issue: 別冊9  Page: 48-64  Publication year: Aug. 05, 2010 
JST Material Number: L5240A  ISSN: 1347-3891  Document type: Article
Article type: 原著論文  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=10A0845291&from=J-GLOBAL&jstjournalNo=L5240A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Metabolic diseases,nutritional diseases in general.  ,  Medical information processing 
Reference (11):
  • Health and Welfare Statistics Association: JOURNAL OF IIEALTH AND WELFARE STATISTICS.2009: 56.9: 230-232, 2009
  • Health and Welfare Statistics Association: JOURNAL OF HEALTH AND WELFARE STATISTICS.2009: 56.9: 81-82, 2009
  • Pelletier EM, Shim B, Ben-Joseph R, et al. Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis. Pharmacoeconomics 27(6): 479-90, 2009
  • Gandra SR, Lawrence LW, Parasuraman BM, et al.: Total and component health care costs in a non Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease../Manag Care Pharm 12(7): 546-554, 2006
  • Pelletier EM, Smith PJ, Boye KS, et al.: Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research. Appl Health Econ Health Policy 6(2-3): 103-112, 2008
more...

Return to Previous Page